Abstract
A series of pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione derivatives was designed and synthesized, and their neuroprotective activity against SH-SY5Y cell injury induced by N-methyl-D-aspartic acid(NMDA) was evaluated. All the compounds showed significant neuroprotective effects, especially B16, which showed excellent performance and better activity than the positive control ifenprodil(B16: 56.2%±0.6%; ifenprodil: 41.0%±2.7%). Further investigation indicated that B16 could attenuate the Ca2+ influx induced by NMDA in SH-SY5Y cells and Western blotting also showed that B16 could attenuate the NR2B upregulation in SH-SY5Y cells induced by NMDA. The molecular docking results showed that compound B16 fitted in the binding pocket of NR2B-NMDAR well and could interact with binding sites of compounds 1 and 2 simultaneously. The ADME/Tox prediction results suggested that compound B16 had good blood-brain barrier(BBB) permeability and the zero alert of Pan Assay Interference Structures(PAINS) indicated that B16 could not elicit false-positive activities. These results strongly suggest that B16 is a promising and effective candidate neuroprotective compound, and that NR2B-NMDAR is a potential target of B16.
Similar content being viewed by others
References
Buemi M. R., De Luca L., Ferro S., Russo E., De Sarro G., Gitto R., Bioorg. Med. Chem., 2016, 24, 1513
Dey S., Schepmann D., Wunsch B., Bioorg. Med. Chem. Lett., 2016, 26, 889
Gitto R., De Luca L., Ferro S., Buemi M. R., Russo E., De Sarro G., Costa L., Ciranna L., Prezzavento O., Arena E., Ronsisvalle S., Bruno, G., Chimirri A., J. Med. Chem., 2011, 54, 8702
Parsons C. G., Danysz W., Quack G., Drug News Perspect, 1998, 11, 523
Tewes B., Frehland B., Schepmann D., Schmidtke K. U., Winckler T., Wunsch B., Bioorg. Med. Chem., 2010, 18, 8005
Cadinu D., Grayson B., Podda G., Harte M. K., Doostdar N., Neill J. C., Neuropharmacology, 2018, 142, 41
Potschka H., Loscher W., Wlaz P., Behl B., Hofmann H. P., Treiber H. J., Szabo L., Br. J. Pharmacol., 1998, 125, 1258
Glynn-Servedio B. E., Ranola T. S., Consult Pharm., 2017, 32, 511
Shi T., Hao J. X., Wiesenfeld-Hallin Z., Xu X. J., Scand. J. Pain., 2018, 18, 687
Milnerwood A. J., Gladding C. M., Pouladi M. A., Kaufman A. M., Hines R. M., Boyd J. D., Ko R. W., Vasuta O. C., Graham R. K., Hayden M. R., Murphy T. H., Raymond L. A., Neuron, 2010, 65, 178
Krausova B., Slavikova B., Nekardova M., Hubalkova P., Vyklicky V., Chodounska H., Vyklicky L., Kudova E., Journal of Medicinal Chemistry, 2018, 61, 4505
von Engelhardt J., Coserea I., Pawlak V., Fuchs E. C., Kohr G., Seeburg P. H., Monyer H., Neuropharmacology, 2007, 53, 10
Loftis J. M., Janowsky A., Pharmacol. Ther., 2003, 97, 55
Furukawa H., Singh S. K., Mancusso R., Gouaux E., Nature, 2005, 438, 185
Williams K., Curr. Drug Targets, 2001, 2, 285
Chenard B. L., Bordner J., Butler T. W., Chambers L. K., Collins M. A., De Costa D. L., Ducat M. F., Dumont M. L., Fox C. B., Journal of Medicinal Chemistry, 1995, 38, 3138
Fischer G., Mutel V., Trube G., Malherbe P., Kew J. N., Mohacsi E., Heitz M. P., Kemp J. A., The Journal of Pharmacology and Experimental Therapeutics, 1997, 283, 1285
Stroebel D., Buhl D. L., Knafels J. D., Chanda P. K., Green M., Sciabola S., Mony L., Paoletti P., Pandit J., Mol. Pharmacol., 2016, 89, 541
Koolen H. H., Pral E. M., Alfieri S. C., Marinho J. V., Serain A. F., Hernandez-Tasco A. J., Andreazza N. L., Salvador M. J., Phytochemistry, 2017, 134, 106
Di Fabio R., Micheli F., Baraldi D., Bertani B., Conti N., Dal Forno G., Feriani A., Donati D., Marchioro C., Messeri T., Missio A., Pasquarello A., Pentassuglia G., Pizzi D. A., Provera S., Quaglia A. M., Sabbatini F. M., II. Farmaco., 2003, 58, 723
Ma C., Du K., Zhao Y., Zhang L. K., Hu B. C., Cheng M. S., Bioorg. Med. Chem., 2018, 26, 5151
Zhang L. K., Zhao Y., Wang J., Yang D. L., Zhao C. W., Wang C. L., Ma C., Cheng M. S., Eur. J. Med. Chem., 2018, 151, 27
Zhang L. K., Quan J. S., Zhao Y., Yang D. L., Zhao Q. C., Liu P., Cheng M. S., Ma C., Eur. J. Med. Chem., 2019, 182, 111654
Feng X. Y., Jia W. Q., Liu X., Jing Z., Liu Y. Y., Xu W. R., Cheng X. C., Comput. Biol. Chem., 2019, 78, 178
Acknowledgements
This work was supported by the National Natural Science Foundation of China(No.21977074) and the Science and Technology Projects from the Educational Department of Liaoning Province, China(No.2019LQN02).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare no conflicts of interest.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Quan, J., Zhang, D., Zhang, Z. et al. Design, Synthesis and Biological Evaluation of Pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione Derivatives as Novel Neuroprotective Agents. Chem. Res. Chin. Univ. 37, 647–654 (2021). https://doi.org/10.1007/s40242-020-0283-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-020-0283-z